Heterocyclic Glp-1 Agonists

Patent No. EP4476216 (titled "Heterocyclic Glp-1 Agonists") was filed by Gasherbrum BIO on Feb 8, 2023. The application was issued on Dec 18, 2024.

Patent Summary

Patent Family

Patent Family

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP4476216

GASHERBRUM BIO
Application Number
EP23752354A
Filing Date
Feb 8, 2023
Status
Request For Examination Was Made
Nov 15, 2024
Publication Date
Dec 18, 2024